BIOLARGO, INC.
Profit Margins
| Period | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| Mar 2017 | 51.0% | -3,109.3% | -5,053.9% |
| Jun 2017 | 26.6% | -1,466.6% | -2,574.7% |
| Sep 2017 | 28.3% | -872.6% | -1,305.5% |
| Dec 2017 | 47.6% | -756.5% | -1,212.9% |
| Mar 2018 | 27.5% | -440.1% | -667.6% |
| Jun 2018 | 38.5% | -497.9% | -1,100.9% |
| Sep 2018 | 56.0% | -601.1% | -858.5% |
| Dec 2018 | 60.6% | -383.1% | -577.8% |
| Mar 2019 | 47.3% | -456.6% | -755.2% |
| Jun 2019 | 46.5% | -349.1% | -466.4% |
| Sep 2019 | 50.2% | -352.8% | -727.7% |
| Dec 2019 | 51.8% | -309.7% | -524.8% |
| Mar 2020 | 40.8% | -387.7% | -595.9% |
| Jun 2020 | 51.9% | -479.7% | -645.9% |
| Sep 2020 | 54.8% | -286.6% | -358.9% |
| Dec 2020 | 51.4% | -216.4% | -219.4% |
| Mar 2021 | 40.6% | -325.4% | -328.9% |
| Jun 2021 | 43.3% | -366.8% | -385.8% |
| Sep 2021 | 49.2% | -204.4% | -201.5% |
| Dec 2021 | 40.8% | -224.9% | -228.4% |
| Mar 2022 | 54.0% | -177.2% | -160.0% |
| Jun 2022 | 47.1% | -99.8% | -100.8% |
| Sep 2022 | 50.1% | -62.9% | -56.5% |
| Dec 2022 | 45.8% | -67.6% | -67.2% |
| Mar 2023 | 48.4% | -12.7% | -13.2% |
| Jun 2023 | 56.6% | -107.8% | -112.4% |
| Sep 2023 | 53.7% | -57.5% | -56.4% |
| Dec 2023 | 47.8% | -23.0% | -23.3% |
| Mar 2024 | 47.2% | -16.0% | -16.3% |
| Jun 2024 | 42.6% | -17.8% | -15.6% |
| Sep 2024 | 39.6% | -24.4% | -24.4% |
| Dec 2024 | 47.8% | -44.3% | -47.4% |
| Mar 2025 | 45.5% | -57.0% | -58.8% |
| Jun 2025 | 51.2% | -64.9% | -67.8% |
| Sep 2025 | 33.7% | -651.0% | -656.8% |
| Dec 2025 | 20.3% | -651.1% | -672.4% |
| Mar 2026 | 41.1% | -287.4% | -305.4% |
| Jun 2026 | 54.1% | -298.7% | -320.5% |